Dr. Rajiv Anant Desai Joins Albert David As Independent Director

Dr. Rajiv Anant Desai has been appointed as Non-Executive Independent Director (Additional Director) of Albert David Limited, w.e.f. August 2, 2025, subject to approval of the shareholders through Postal Ballot.

Dr. Desai is a pharmaceutical professional with over 38 years of global experience. Since July 2022, he has been serving as Senior Technical Advisor of Quality and Regulatory at the Indian Pharmaceutical Alliance (IPA) while also working as an independent consultant and advisor to the pharma industry. He has held senior roles, including Executive Vice President of Global Corporate Quality at Lupin Ltd., and began his career with Ciba Geigy (now Novartis). He is a member of the Indian and US Pharmacopoeia committees, and he is also a visiting faculty and board member at leading academic institutions. Dr. Desai holds an M.Sc. in Chemistry from Mumbai University, a Ph.D. in Pharmaceutical Chemistry from ICT Mumbai, and an MBA from NMIMS, Mumbai.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: